Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenylketonurias | 2 | 2019 | 12 | 1.110 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 357 | 0.760 |
Why?
|
| Neonatal Screening | 2 | 2019 | 163 | 0.660 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2019 | 1 | 0.650 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2024 | 154 | 0.650 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2018 | 111 | 0.520 |
Why?
|
| Genotype | 2 | 2019 | 1829 | 0.470 |
Why?
|
| Phenotype | 5 | 2024 | 3062 | 0.460 |
Why?
|
| Intellectual Disability | 3 | 2024 | 148 | 0.400 |
Why?
|
| Mutation | 5 | 2021 | 3705 | 0.380 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 778 | 0.370 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 486 | 0.360 |
Why?
|
| Exome | 2 | 2023 | 216 | 0.340 |
Why?
|
| Nerve Tissue Proteins | 2 | 2024 | 569 | 0.310 |
Why?
|
| Autism Spectrum Disorder | 2 | 2023 | 386 | 0.270 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2024 | 1 | 0.220 |
Why?
|
| Visual Fields | 1 | 2024 | 87 | 0.210 |
Why?
|
| Eye Proteins | 1 | 2024 | 88 | 0.210 |
Why?
|
| Microcephaly | 1 | 2024 | 87 | 0.210 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2022 | 13 | 0.200 |
Why?
|
| Alleles | 3 | 2020 | 843 | 0.200 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 25 | 0.200 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 186 | 0.200 |
Why?
|
| Intracranial Hypertension | 1 | 2022 | 37 | 0.190 |
Why?
|
| Symporters | 1 | 2022 | 56 | 0.190 |
Why?
|
| Visual Acuity | 1 | 2024 | 326 | 0.190 |
Why?
|
| Myopia, Degenerative | 1 | 2021 | 4 | 0.180 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 11 | 0.180 |
Why?
|
| Semaphorins | 1 | 2021 | 28 | 0.180 |
Why?
|
| RNA Helicases | 1 | 2021 | 24 | 0.180 |
Why?
|
| Autistic Disorder | 1 | 2023 | 189 | 0.180 |
Why?
|
| Graves Disease | 1 | 2020 | 34 | 0.170 |
Why?
|
| Cerebellar Diseases | 1 | 2020 | 23 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 173 | 0.170 |
Why?
|
| Retinal Diseases | 1 | 2021 | 87 | 0.170 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 53 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2024 | 1119 | 0.170 |
Why?
|
| Genomic Imprinting | 1 | 2020 | 25 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 36 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 443 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 381 | 0.160 |
Why?
|
| Conserved Sequence | 1 | 2020 | 227 | 0.160 |
Why?
|
| Dicarboxylic Acid Transporters | 1 | 2018 | 2 | 0.150 |
Why?
|
| Alopecia | 1 | 2018 | 30 | 0.150 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 42 | 0.150 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2018 | 11 | 0.150 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 34 | 0.150 |
Why?
|
| Megalencephaly | 1 | 2018 | 19 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 284 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2020 | 274 | 0.150 |
Why?
|
| Cataract | 1 | 2021 | 208 | 0.150 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2018 | 5 | 0.150 |
Why?
|
| Infant, Newborn | 2 | 2019 | 5759 | 0.140 |
Why?
|
| Pancreatitis | 1 | 2018 | 129 | 0.140 |
Why?
|
| Disease Resistance | 1 | 2016 | 31 | 0.130 |
Why?
|
| Mutation, Missense | 3 | 2024 | 316 | 0.130 |
Why?
|
| Humans | 16 | 2024 | 129687 | 0.110 |
Why?
|
| Loss of Function Mutation | 2 | 2024 | 38 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2271 | 0.100 |
Why?
|
| Male | 11 | 2024 | 63691 | 0.100 |
Why?
|
| United States | 2 | 2019 | 13906 | 0.090 |
Why?
|
| Retina | 2 | 2024 | 283 | 0.090 |
Why?
|
| Child | 7 | 2024 | 20882 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2024 | 10487 | 0.070 |
Why?
|
| Infant | 4 | 2024 | 8987 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2019 | 10221 | 0.060 |
Why?
|
| Dark Adaptation | 1 | 2024 | 14 | 0.060 |
Why?
|
| Retinal Dystrophies | 1 | 2024 | 5 | 0.060 |
Why?
|
| Visual Field Tests | 1 | 2024 | 16 | 0.060 |
Why?
|
| Glycogen | 1 | 2023 | 55 | 0.050 |
Why?
|
| Protein Phosphatase 1 | 1 | 2023 | 33 | 0.050 |
Why?
|
| Syndrome | 1 | 2024 | 337 | 0.050 |
Why?
|
| Female | 5 | 2024 | 68751 | 0.050 |
Why?
|
| Adolescent | 4 | 2024 | 20415 | 0.050 |
Why?
|
| Hemizygote | 1 | 2022 | 3 | 0.050 |
Why?
|
| Maternal Inheritance | 1 | 2022 | 15 | 0.050 |
Why?
|
| Heterozygote | 1 | 2023 | 271 | 0.050 |
Why?
|
| Mydriatics | 1 | 2021 | 3 | 0.050 |
Why?
|
| Tetraspanins | 1 | 2021 | 18 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2022 | 218 | 0.050 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2020 | 5 | 0.040 |
Why?
|
| Thyroxine | 1 | 2020 | 62 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2020 | 40 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 140 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2020 | 87 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 195 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 317 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 379 | 0.040 |
Why?
|
| Pedigree | 1 | 2021 | 483 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 128 | 0.040 |
Why?
|
| Protein Folding | 1 | 2020 | 265 | 0.040 |
Why?
|
| Facies | 1 | 2018 | 19 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 228 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 697 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 247 | 0.040 |
Why?
|
| Brain | 2 | 2022 | 2677 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 1003 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1716 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 460 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1690 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 12457 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2018 | 279 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 408 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1465 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 35404 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 104 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 4892 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 1016 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 1774 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2062 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3969 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4935 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 14525 | 0.020 |
Why?
|
| Mice | 1 | 2020 | 16982 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 35607 | 0.010 |
Why?
|